Rallis India Limited, a TATA Enterprise and a leading player in India’s agricultural inputs sector, announced its financial results for the second quarter and half year ended September 30, 2025, reporting stable profitability despite adverse monsoon patterns that affected field activity and product demand across key markets.

During the quarter, the company posted revenue of Rs 861 crore, compared to Rs 928 crore in the same period last year, as erratic and prolonged rains delayed crop cycles and reduced spray applications. However, profit after tax rose 4 per cent to Rs 102 crore from Rs 98 crore in Q2 FY25, with PAT margins improving by 120 basis points to 11.8 per cent. EBITDA for the quarter stood at Rs 154 crore versus Rs 166 crore last year. Strong cash generation continued, supported by disciplined operations and cost optimization, resulting in a Free Cash Flow of Rs 52 crore, zero external debt, and a healthy closing cash and liquid balance of Rs 454 crore.

For the half year, Rallis reported revenue of Rs 1,818 crore, a 6 per cent increase over Rs 1,711 crore in H1 FY25. EBITDA rose 16 per cent to Rs 303 crore from Rs 261 crore, while PAT increased 35 per cent to Rs 197 crore from Rs 146 crore during the previous year’s period. The company achieved a PAT margin of 10.8 per cent, up from 8.5 per cent a year earlier, reflecting stronger operational efficiency and a richer product mix.

Business performance during the quarter reflected varying market conditions across segments. The Crop Care B2B business delivered 14 per cent year-on-year growth driven by volume revival in key molecules and improved capacity utilization, while the Crop Protection B2C business declined 10 per cent due to weather-related disruptions.

Soil & Plant Health faced a 20 per cent contraction, impacted by regulatory challenges in the biostimulants category. Exports, however, were a standout performer, rising 33 per cent on increased volume traction in strategic molecules. The Seeds business closed the quarter at Rs 101 crore, compared to Rs 141 crore last year, with supply chain constraints affecting volumes, though improved pricing and margins helped cushion the impact.

The company continued to invest in portfolio expansion, launching eight new products during the first half of the fiscal year, including Penflor, Allato, Deeweed, Dodrio, Master Gold, Torris, Vaar and Teer, strengthening its offerings across herbicides and fungicides. It also resumed in-house biostimulant production, reinforcing its position in sustainable crop input solutions.

Commenting on the performance, Dr. Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said: “Q2 was challenging due to prolonged rains affecting field activities and product placement. Despite these headwinds, we maintained steady profitability, supported by export momentum, prudent cost management, and improved margins in the Seeds business. Our strong balance sheet, zero external debt, and healthy liquidity reflect our financial discipline and operational resilience.”

With continued focus on innovation, export expansion, and supply chain optimization, Rallis said it remains positioned to navigate climatic volatility while advancing its portfolio of crop protection and sustainable agricultural solutions for Indian and global markets.